Fulgent Genetics (FLGT) Current Leases (2019 - 2026)

Fulgent Genetics has disclosed Current Leases across 8 years of filings, most recently posting $1.9 million for Q1 2026.

• Current Leases for Q1 2026 came in at $1.9 million, up 45.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (up 45.26% YoY), and the FY2025 annual result was $1.5 million, up 1.32% from the prior year.
• Current Leases came in at $1.9 million for Q1 2026 at Fulgent Genetics, up from $1.5 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $6.1 million in Q4 2022 to a low of $1.2 million in Q2 2025.
• The 5-year median for Current Leases is $1.5 million (2025), against an average of $2.3 million.
• Across the five-year window, Current Leases slumped 63.53% in 2024 and jumped 45.26% in 2026, its largest moves.
• Fulgent Genetics' Current Leases stood at $6.1 million in 2022, then plunged by 35.47% to $4.0 million in 2023, then plunged by 63.53% to $1.4 million in 2024, then increased by 1.32% to $1.5 million in 2025, then jumped by 32.15% to $1.9 million in 2026.
• The last three Current Leases figures came in at $1.9 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.